Europe Chimeric Antibody Market Research Report Forecast 2017-2021

June 2017 | 113 pages | ID: EC7D50F2992EN
S&P Consulting

Abstracts

The Europe Chimeric Antibody Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Chimeric Antibody industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Chimeric Antibody market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

Europe Chimeric Antibody Market Analysis by Countries:

Germany
France
UK
Russia
Italy
Spain
Benelux

The Major players reported in the market include:

Agilent Technologies
BD Biosciences
Beckman Coulter
bioMerieux
Bio-Rad Laboratories
F.Hoffmann-La Roche
Gallus Immunotech
GE Healthcare
Lonza Biologics Ltd

Europe Chimeric Antibody Market Analysis by Product :

• Type 1
• Type 2
• Type 3

Europe Chimeric Antibody Market Analysis by Application:

• Application 1
• Application 2
• Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Contents

1 CHIMERIC ANTIBODY MARKET OVERVIEW

1.1 Product Overview and Scope of Chimeric Antibody
1.2 Classification of Chimeric Antibody
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Application of Chimeric Antibody
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Chimeric Antibody Market States Status and Prospect (2012-2021) by Countries
  1.4.1 Germany
  1.4.2 France
  1.4.3 UK
  1.4.4 Russia
  1.4.5 Italy
  1.4.6 Spain
  1.4.7 Benelux
1.5 Europe Market Size (Value and Volume) of Chimeric Antibody (2012-2021)
  1.5.1 Europe Chimeric Antibody Sales and Growth Rate (2012-2021)
  1.5.2 Europe Chimeric Antibody Revenue and Growth Rate (2012-2021)

2 EUROPE ECONOMIC IMPACT ON CHIMERIC ANTIBODY INDUSTRY

2.1 Europe Macroeconomic Analysis
2.2 Europe Macroeconomic Environment Development Trend

3 CHIMERIC ANTIBODY MANUFACTURING COST ANALYSIS

3.1 Chimeric Antibody Key Raw Materials Analysis
  3.1.1 Key Raw Materials
  3.1.2 Price Trend of Key Raw Materials
  3.1.3 Key Suppliers of Raw Materials
  3.1.4 Market Concentration Rate of Raw Materials
3.2 Proportion of Manufacturing Cost Structure
  3.2.1 Raw Materials
  3.2.2 Labor Cost
  3.2.3 Manufacturing Process Analysis of Chimeric Antibody

4 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

4.1 Chimeric Antibody Industrial Chain Analysis
4.2 Upstream Raw Materials Sourcing
4.3 Raw Materials Sources of Chimeric Antibody Major Manufacturers in 2015
4.4 Downstream Buyers

5 EUROPE CHIMERIC ANTIBODY MARKET ANALYSIS BY MANUFACTURERS, TYPE AND APPLICATION

5.1 Europe Chimeric Antibody Market Competition by Manufacturers
  5.1.1 Europe Chimeric Antibody Sales and Market Share of Key Manufacturers (2015 and 2016)
  5.1.2 Europe Chimeric Antibody Revenue and Share by Manufacturers (2015 and 2016)
5.2 Europe Chimeric Antibody (Volume and Value) by Type
  5.2.1 Europe Chimeric Antibody Sales and Market Share by Type (2012-2017)
  5.2.2 Europe Chimeric Antibody Revenue and Market Share by Type (2012-2017)
5.3 Europe Chimeric Antibody (Volume and Value) by Countries
  5.3.1 Europe Chimeric Antibody Sales and Market Share by Countries (2012-2017)
  5.3.2 Europe Chimeric Antibody Revenue and Market Share by Countries (2012-2017)
5.4 Europe Chimeric Antibody (Volume) by Application

6 GERMANY CHIMERIC ANTIBODY (VOLUME, VALUE AND SALES PRICE)

6.1 Germany Chimeric Antibody Sales and Value (2012-2017)
  6.1.1 Germany Chimeric Antibody Sales and Growth Rate (2012-2017)
  6.1.2 Germany Chimeric Antibody Revenue and Growth Rate (2012-2017)
  6.1.3 Germany Chimeric Antibody Sales Price Trend (2012-2017)
6.2 Germany Chimeric Antibody Sales and Market Share by Manufacturers
6.3 Germany Chimeric Antibody Sales and Market Share by Type
6.4 Germany Chimeric Antibody Sales and Market Share by Application

7 FRANCE CHIMERIC ANTIBODY (VOLUME, VALUE AND SALES PRICE)

7.1 France Chimeric Antibody Sales and Value (2012-2017)
  7.1.1 France Chimeric Antibody Sales and Growth Rate (2012-2017)
  7.1.2 France Chimeric Antibody Revenue and Growth Rate (2012-2017)
  7.1.3 France Chimeric Antibody Sales Price Trend (2012-2017)
7.2 France Chimeric Antibody Sales and Market Share by Manufacturers
7.3 France Chimeric Antibody Sales and Market Share by Type
7.4 France Chimeric Antibody Sales and Market Share by Application

8 UK CHIMERIC ANTIBODY (VOLUME, VALUE AND SALES PRICE)

8.1 UK Chimeric Antibody Sales and Value (2012-2017)
  8.1.1 UK Chimeric Antibody Sales and Growth Rate (2012-2017)
  8.1.2 UK Chimeric Antibody Revenue and Growth Rate (2012-2017)
  8.1.3 UK Chimeric Antibody Sales Price Trend (2012-2017)
8.2 UK Chimeric Antibody Sales and Market Share by Manufacturers
8.3 UK Chimeric Antibody Sales and Market Share by Type
8.4 UK Chimeric Antibody Sales and Market Share by Application

9 RUSSIA CHIMERIC ANTIBODY (VOLUME, VALUE AND SALES PRICE)

9.1 Russia Chimeric Antibody Sales and Value (2012-2017)
  9.1.1 Russia Chimeric Antibody Sales and Growth Rate (2012-2017)
  9.1.2 Russia Chimeric Antibody Revenue and Growth Rate (2012-2017)
  9.1.3 Russia Chimeric Antibody Sales Price Trend (2012-2017)
9.2 Russia Chimeric Antibody Sales and Market Share by Manufacturers
9.3 Russia Chimeric Antibody Sales and Market Share by Type
9.4 Russia Chimeric Antibody Sales and Market Share by Application

10 ITALY CHIMERIC ANTIBODY (VOLUME, VALUE AND SALES PRICE)

10.1 Italy Chimeric Antibody Sales and Value (2012-2017)
  10.1.1 Italy Chimeric Antibody Sales and Growth Rate (2012-2017)
  10.1.2 Italy Chimeric Antibody Revenue and Growth Rate (2012-2017)
  10.1.3 Italy Chimeric Antibody Sales Price Trend (2012-2017)
10.2 Italy Chimeric Antibody Sales and Market Share by Manufacturers
10.3 Italy Chimeric Antibody Sales and Market Share by Type
10.4 Italy Chimeric Antibody Sales and Market Share by Application

11 SPAIN CHIMERIC ANTIBODY (VOLUME, VALUE AND SALES PRICE)

11.1 Spain Chimeric Antibody Sales and Value (2012-2017)
  11.1.1 Spain Chimeric Antibody Sales and Growth Rate (2012-2017)
  11.1.2 Spain Chimeric Antibody Revenue and Growth Rate (2012-2017)
  11.1.3 Spain Chimeric Antibody Sales Price Trend (2012-2017)
11.2 Spain Chimeric Antibody Sales and Market Share by Manufacturers
11.3 Spain Chimeric Antibody Sales and Market Share by Type
11.4 Spain Chimeric Antibody Sales and Market Share by Application

12 BENELUX CHIMERIC ANTIBODY (VOLUME, VALUE AND SALES PRICE)

12.1 Benelux Chimeric Antibody Sales and Value (2012-2017)
  12.1.1 Benelux Chimeric Antibody Sales and Growth Rate (2012-2017)
  12.1.2 Benelux Chimeric Antibody Revenue and Growth Rate (2012-2017)
  12.1.3 Benelux Chimeric Antibody Sales Price Trend (2012-2017)
12.2 Benelux Chimeric Antibody Sales and Market Share by Manufacturers
12.3 Benelux Chimeric Antibody Sales and Market Share by Type
12.4 Benelux Chimeric Antibody Sales and Market Share by Application

13 EUROPE CHIMERIC ANTIBODY MANUFACTURERS ANALYSIS

13.1 Agilent Technologies
  13.1.1 Company Basic Information, Manufacturing Base and Competitors
  13.1.2 Product Type, Application and Specification
  13.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.1.4 Business Overview
13.2 BD Biosciences
  13.2.1 Company Basic Information, Manufacturing Base and Competitors
  13.2.2 Product Type, Application and Specification
  13.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.2.4 Business Overview
13.3 Beckman Coulter
  13.3.1 Company Basic Information, Manufacturing Base and Competitors
  13.3.2 Product Type, Application and Specification
  13.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.3.4 Business Overview
13.4 bioMerieux
  13.4.1 Company Basic Information, Manufacturing Base and Competitors
  13.4.2 Product Type, Application and Specification
  13.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.4.4 Business Overview
13.5 Bio-Rad Laboratories
  13.5.1 Company Basic Information, Manufacturing Base and Competitors
  13.5.2 Product Type, Application and Specification
  13.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.5.4 Business Overview
13.6 F.Hoffmann-La Roche
  13.6.1 Company Basic Information, Manufacturing Base and Competitors
  13.6.2 Product Type, Application and Specification
  13.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.6.4 Business Overview
13.7 Gallus Immunotech
  13.7.1 Company Basic Information, Manufacturing Base and Competitors
  13.7.2 Product Type, Application and Specification
  13.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.7.4 Business Overview
13.8 GE Healthcare
  13.8.1 Company Basic Information, Manufacturing Base and Competitors
  13.8.2 Product Type, Application and Specification
  13.8.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.8.4 Business Overview
13.9 Lonza Biologics Ltd
  13.9.1 Company Basic Information, Manufacturing Base and Competitors
  13.9.2 Product Type, Application and Specification
  13.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.9.4 Business Overview

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 EUROPE CHIMERIC ANTIBODY MARKET FORECAST (2017-2021)

15.1 Germany Market Forecast (2017-2021)
15.2 France Market Forecast (2017-2021)
15.3 UK Market Forecast (2017-2021)
15.4 Russia Market Forecast (2017-2021)
15.5 Italy Market Forecast (2017-2021)
15.6 Spain Market Forecast (2017-2021)
15.7 Benelux Market Forecast (2017-2021)
15.8 Europe Chimeric Antibody Market Forecast by Type (2017-2021)
15.9 Europe Chimeric Antibody Market Forecast by Application (2017-2021)

16 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Chimeric Antibody
Table Classification of Chimeric Antibody
Figure Europe Sales Market Share of Chimeric Antibody by Type in 2015
Table Application of Chimeric Antibody
Figure Europe Sales Market Share of Chimeric Antibody by Application in 2015
Figure Germany Chimeric Antibody Revenue and Growth Rate (2012-2021)
Figure France Chimeric Antibody Revenue and Growth Rate (2012-2021)
Figure UK Chimeric Antibody Revenue and Growth Rate (2012-2021)
Figure Russia Chimeric Antibody Revenue and Growth Rate (2012-2021)
Figure Italy Chimeric Antibody Revenue and Growth Rate (2012-2021)
Figure Spain Chimeric Antibody Revenue and Growth Rate (2012-2021)
Figure Benelux Chimeric Antibody Revenue and Growth Rate (2012-2021)
Figure Europe Chimeric Antibody Sales and Growth Rate (2012-2021)
Figure Europe Chimeric Antibody Revenue and Growth Rate (2012-2021)
Table Europe Chimeric Antibody Sales of Key Manufacturers (2015 and 2016)
Table Europe Chimeric Antibody Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Chimeric Antibody Sales Share by Manufacturers
Figure 2016 Chimeric Antibody Sales Share by Manufacturers
Table Europe Chimeric Antibody Revenue by Manufacturers (2015 and 2016)
Table Europe Chimeric Antibody Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Chimeric Antibody Revenue Share by Manufacturers
Table 2016 Europe Chimeric Antibody Revenue Share by Manufacturers
Table Europe Chimeric Antibody Sales and Market Share by Type (2012-2017)
Table Europe Chimeric Antibody Sales Share by Type (2012-2017)
Figure Sales Market Share of Chimeric Antibody by Type (2012-2017)
Figure Europe Chimeric Antibody Sales Growth Rate by Type (2012-2017)
Table Europe Chimeric Antibody Revenue and Market Share by Type (2012-2017)
Table Europe Chimeric Antibody Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Chimeric Antibody by Type (2012-2017)
Figure Europe Chimeric Antibody Revenue Growth Rate by Type (2012-2017)
Table Europe Chimeric Antibody Sales and Market Share by Countries (2012-2017)
Table Europe Chimeric Antibody Sales Share by Countries (2012-2017)
Figure Sales Market Share of Chimeric Antibody by Countries (2012-2017)
Table Europe Chimeric Antibody Revenue and Market Share by Countries (2012-2017)
Table Europe Chimeric Antibody Revenue Share by Countries (2012-2017)
Figure Revenue Market Share of Chimeric Antibody by Countries (2012-2017)
Table Europe Chimeric Antibody Sales and Market Share by Application (2012-2017)
Table Europe Chimeric Antibody Sales Share by Application (2012-2017)
Figure Sales Market Share of Chimeric Antibody by Application (2012-2017)
Figure Germany Chimeric Antibody Sales and Growth Rate (2012-2017)
Figure Germany Chimeric Antibody Revenue and Growth Rate (2012-2017)
Figure Germany Chimeric Antibody Sales Price Trend (2012-2017)
Table Germany Chimeric Antibody Sales by Manufacturers (2015 and 2016)
Table Germany Chimeric Antibody Market Share by Manufacturers (2015 and 2016)
Table Germany Chimeric Antibody Sales by Type (2015 and 2016)
Table Germany Chimeric Antibody Market Share by Type (2015 and 2016)
Table Germany Chimeric Antibody Sales by Application (2015 and 2016)
Table Germany Chimeric Antibody Market Share by Application (2015 and 2016)
Figure France Chimeric Antibody Sales and Growth Rate (2012-2017)
Figure France Chimeric Antibody Revenue and Growth Rate (2012-2017)
Figure France Chimeric Antibody Sales Price Trend (2012-2017)
Table France Chimeric Antibody Sales by Manufacturers (2015 and 2016)
Table France Chimeric Antibody Market Share by Manufacturers (2015 and 2016)
Table France Chimeric Antibody Sales by Type (2015 and 2016)
Table France Chimeric Antibody Market Share by Type (2015 and 2016)
Table France Chimeric Antibody Sales by Application (2015 and 2016)
Table France Chimeric Antibody Market Share by Application (2015 and 2016)
Figure UK Chimeric Antibody Sales and Growth Rate (2012-2017)
Figure UK Chimeric Antibody Revenue and Growth Rate (2012-2017)
Figure UK Chimeric Antibody Sales Price Trend (2012-2017)
Table UK Chimeric Antibody Sales by Manufacturers (2015 and 2016)
Table UK Chimeric Antibody Market Share by Manufacturers (2015 and 2016)
Table UK Chimeric Antibody Sales by Type (2015 and 2016)
Table UK Chimeric Antibody Market Share by Type (2015 and 2016)
Table UK Chimeric Antibody Sales by Application (2015 and 2016)
Table UK Chimeric Antibody Market Share by Application (2015 and 2016)
Figure Russia Chimeric Antibody Sales and Growth Rate (2012-2017)
Figure Russia Chimeric Antibody Revenue and Growth Rate (2012-2017)
Figure Russia Chimeric Antibody Sales Price Trend (2012-2017)
Table Russia Chimeric Antibody Sales by Manufacturers (2015 and 2016)
Table Russia Chimeric Antibody Market Share by Manufacturers (2015 and 2016)
Table Russia Chimeric Antibody Sales by Type (2015 and 2016)
Table Russia Chimeric Antibody Market Share by Type (2015 and 2016)
Table Russia Chimeric Antibody Sales by Application (2015 and 2016)
Table Russia Chimeric Antibody Market Share by Application (2015 and 2016)
Figure Italy Chimeric Antibody Sales and Growth Rate (2012-2017)
Figure Italy Chimeric Antibody Revenue and Growth Rate (2012-2017)
Figure Italy Chimeric Antibody Sales Price Trend (2012-2017)
Table Italy Chimeric Antibody Sales by Manufacturers (2015 and 2016)
Table Italy Chimeric Antibody Market Share by Manufacturers (2015 and 2016)
Table Italy Chimeric Antibody Sales by Type (2015 and 2016)
Table Italy Chimeric Antibody Market Share by Type (2015 and 2016)
Table Italy Chimeric Antibody Sales by Application (2015 and 2016)
Table Italy Chimeric Antibody Market Share by Application (2015 and 2016)
Figure Spain Chimeric Antibody Sales and Growth Rate (2012-2017)
Figure Spain Chimeric Antibody Revenue and Growth Rate (2012-2017)
Figure Spain Chimeric Antibody Sales Price Trend (2012-2017)
Table Spain Chimeric Antibody Sales by Manufacturers (2015 and 2016)
Table Spain Chimeric Antibody Market Share by Manufacturers (2015 and 2016)
Table Spain Chimeric Antibody Sales by Type (2015 and 2016)
Table Spain Chimeric Antibody Market Share by Type (2015 and 2016)
Table Spain Chimeric Antibody Sales by Application (2015 and 2016)
Table Spain Chimeric Antibody Market Share by Application (2015 and 2016)
Figure Benelux Chimeric Antibody Sales and Growth Rate (2012-2017)
Figure Benelux Chimeric Antibody Revenue and Growth Rate (2012-2017)
Figure Benelux Chimeric Antibody Sales Price Trend (2012-2017)
Table Benelux Chimeric Antibody Sales by Manufacturers (2015 and 2016)
Table Benelux Chimeric Antibody Market Share by Manufacturers (2015 and 2016)
Table Benelux Chimeric Antibody Sales by Type (2015 and 2016)
Table Benelux Chimeric Antibody Market Share by Type (2015 and 2016)
Table Benelux Chimeric Antibody Sales by Application (2015 and 2016)
Table Benelux Chimeric Antibody Market Share by Application (2015 and 2016)
Table Agilent Technologies Basic Information List
Table Agilent Technologies Chimeric Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Agilent Technologies Chimeric Antibody Sales Market Share (2012-2017)
Table BD Biosciences Basic Information List
Table BD Biosciences Chimeric Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
Table BD Biosciences Chimeric Antibody Sales Market Share (2012-2017)
Table Beckman Coulter Basic Information List
Table Beckman Coulter Chimeric Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Beckman Coulter Chimeric Antibody Sales Market Share (2012-2017)
Table bioMerieux Basic Information List
Table bioMerieux Chimeric Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
Table bioMerieux Chimeric Antibody Sales Market Share (2012-2017)
Table Bio-Rad Laboratories Basic Information List
Table Bio-Rad Laboratories Chimeric Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Bio-Rad Laboratories Chimeric Antibody Sales Market Share (2012-2017)
Table F.Hoffmann-La Roche Basic Information List
Table F.Hoffmann-La Roche Chimeric Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
Table F.Hoffmann-La Roche Chimeric Antibody Sales Market Share (2012-2017)
Table Gallus Immunotech Basic Information List
Table Gallus Immunotech Chimeric Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Gallus Immunotech Chimeric Antibody Sales Market Share (2012-2017)
Table GE Healthcare Basic Information List
Table GE Healthcare Chimeric Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
Table GE Healthcare Chimeric Antibody Sales Market Share (2012-2017)
Table Lonza Biologics Ltd Basic Information List
Table Lonza Biologics Ltd Chimeric Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Lonza Biologics Ltd Chimeric Antibody Sales Market Share (2012-2017).
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Chimeric Antibody
Figure Manufacturing Process Analysis of Chimeric Antibody
Figure Chimeric Antibody Industrial Chain Analysis
Table Raw Materials Sources of Chimeric Antibody Major Manufacturers in 2015
Table Major Buyers of Chimeric Antibody
Table Distributors/Traders List
Figure Germany Chimeric Antibody Sales and Growth Rate Forecast (2017-2021)
Figure Germany Chimeric Antibody Revenue and Growth Rate Forecast (2017-2021)
Figure France Chimeric Antibody Sales and Growth Rate Forecast (2017-2021)
Figure France Chimeric Antibody Revenue and Growth Rate Forecast (2017-2021)
Figure UK Chimeric Antibody Sales and Growth Rate Forecast (2017-2021)
Figure UK Chimeric Antibody Revenue and Growth Rate Forecast (2017-2021)
Figure Russia Chimeric Antibody Sales and Growth Rate Forecast (2017-2021)
Figure Russia Chimeric Antibody Revenue and Growth Rate Forecast (2017-2021)
Figure Italy Chimeric Antibody Sales and Growth Rate Forecast (2017-2021)
Figure Italy Chimeric Antibody Revenue and Growth Rate Forecast (2017-2021)
Figure Spain Chimeric Antibody Sales and Growth Rate Forecast (2017-2021)
Figure Spain Chimeric Antibody Revenue and Growth Rate Forecast (2017-2021)
Figure Benelux Chimeric Antibody Sales and Growth Rate Forecast (2017-2021)
Figure Benelux Chimeric Antibody Revenue and Growth Rate Forecast (2017-2021)
Table Europe Chimeric Antibody Sales Forecast by Type (2017-2021)
Table Europe Chimeric Antibody Sales Forecast by Application (2017-2021)